期刊文献+

双丹明目胶囊抑制人脐静脉内皮细胞增殖有效成分筛选研究 被引量:4

Study on Screening of Effective Components in Shuangdan Mingmu Capsules in Inhibiting Proliferation of Human Umbilical Vein Endothelial Cells
下载PDF
导出
摘要 目的从双丹明目胶囊24个入血成分中筛选出抑制人脐静脉内皮细胞(HUVEC)增殖的有效成分。方法将双丹明目胶囊24个入血成分标准品均稀释成终浓度为1、10、100μg/mL的溶液,分别干预体外培养的HUVEC,采用MTT法检测细胞存活率,对各成分进行初筛,再对有效成分进行浓度细化,确定有效成分的最佳作用浓度。在此基础上,采用Hoechst33258荧光染色和流式细胞术检测各有效成分对HUVEC凋亡的影响。结果 MTT检测结果显示,双丹明目胶囊24个入血成分中4个成分能有效抑制HUVEC增殖(P<0.05),分别为3-乙酸齐墩果酸、丹参酮ⅡA、芹菜素和大波斯菊苷,其最佳作用浓度分别为75、75、50、75μg/mL;进一步研究发现,上述4个成分均能使HUVEC细胞核固缩、碎裂,数量减少,细胞凋亡率显著增加(P<0.05),其中以丹参酮ⅡA和芹菜素效果尤为明显。结论 3-乙酸齐墩果酸、丹参酮ⅡA、芹菜素和大波斯菊苷是双丹明目胶囊抑制HUVEC增殖、发挥治疗糖尿病视网膜病变疗效的有效成分。 Objective To screen out the effective components inhibiting the proliferation of human umbilical vein endothelial cells(HUVEC)from 24 blood components of Shuangdan Mingmu Capsules.Methods All the 24 standards were diluted to a final concentration of 1,10,and 100μg/mL,and the HUVEC were cultured in vitro.The cell proliferation inhibition rate was measured by MTT method,and the components were screened.Concentration refinement was used to determine the optimal concentration of effective components.Hoechst33258 fluorescence staining and flow cytometry were used to detect the effects of various effective components on apoptosis of HUVEC.Results The results of MTT experiment showed that among the 24 blood components of Shuangdan Mingmu Capsules,4 components could effectively inhibit the proliferation of HUVEC(P<0.05),that were 3-acetate oleanolic acid,tanshinoneⅡA,apigenin and cosmosin,and the optimal concentrations were 75,75,50,and 75μg/mL,respectively.Further studies found that the above four components could make the nucleus of HUVEC pyknosis,fragmentation,number decreased,and the apoptotic rate increased significantly(P<0.05),especially the effect of tanshinoneⅡA and apigenin.Conclusion 3-acetyl oleanolic acid,tanshinoneⅡA,apigenin and cosmosin are effective components of Shuangdan Mingmu Capsules for inhibiting the proliferation of HUVEC and treating diabetic retinopathy.
作者 赵洪庆 符超君 孟盼 王宇红 秦裕辉 张秀丽 ZHAO Hongqing;FU Chaojun;MENG Pan;WANG Yuhong;QIN Yuhui;ZHANG Xiuli(Hunan University of Chinese Medicine,Changsha 410208,China)
机构地区 湖南中医药大学
出处 《中国中医药信息杂志》 CAS CSCD 2019年第7期48-51,共4页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家自然科学基金面上项目(81473737、81874493) 国家自然科学基金青年基金(81603608)
关键词 双丹明目胶囊 人脐静脉内皮细胞 增殖 有效成分筛选 芹菜素 丹参酮ⅡA Shuangdan Mingmu Capsules HUVEC proliferation screening of effective components apigenin tanshinoneⅡA
  • 相关文献

参考文献6

二级参考文献85

  • 1何剑峰,杜娟,唐柳萍,李向荣,黄艳霞.糖尿病大鼠视网膜微血管变化与血液流变学的关系[J].中国临床康复,2005,9(31):93-95. 被引量:9
  • 2宋振英主编.眼科诊断学[M].第1版.北京:人民卫生出版社.1985:577-579.
  • 3Reichenbach A, Bringmann A. New functions of Müller cells. Glia2013; 61: 651-678 [PMID: 23440929 DOI: 10.1002/glia.22477].
  • 4Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW.Diabetic retinopathy: more than meets the eye. Surv Ophthalmol2002; 47 Suppl 2: S253-S262 [PMID: 12507627 DOI: 10.1016/S0039-6257(02)00387-9].
  • 5Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdownin diabetes and ischemia. Invest Ophthalmol Vis Sci 2011; 52:2160-2164 [PMID: 21178141 DOI: 10.1167/iovs.10-6518].
  • 6Xu HZ, Song Z, Fu S, Zhu M, Le YZ. RPE barrier breakdown indiabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor 2011; 4:83-92 [PMID: 23275801 DOI: 10.1007/s12177-011-9068-4].
  • 7Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, SambamurtiK. Pigment epithelium-derived factor maintains retinal pigmentepithelium function by inhibiting vascular endothelial growthfactor-R2 signaling through gamma-secretase. J Biol Chem2009; 284: 30177-30186 [PMID: 19723623 DOI: 10.1074/jbc.M109.032391].
  • 8Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachmentin diabetic cystoid macular oedema. Acta Ophthalmol Scand 2005;83: 63-66 [PMID: 15715559 DOI: 10.1111/j.1600-0420.2005.00387.x].
  • 9Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Deathof retinal neurons in streptozotocin-induced diabetic mice. InvestOphthalmol Vis Sci 2004; 45: 3330-3336 [PMID: 15326158 DOI:10.1167/iovs.04-0247].
  • 10Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, NakamuraM. New insights into the pathophysiology of diabetic retinopathy:potential cell-specific therapeutic targets. Diabetes Technol Ther2000; 2: 601-608 [PMID: 11469624 DOI: 10.1089/15209150050502023].

共引文献47

同被引文献45

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部